TELIF (Telescope Innovations) Market Cap: $43.81 Mil (As of Jun. 28, 2026)


TELIF Telescope Innovations Corp TELIF
33 GF Score
Price $0.56
GF Value $0.39
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Market Cap?

Telescope Innovations TELIF -3.67% 33 Market Cap is $43.81 Mil as of Jun. 28, 2026. GuruFocus rates TELIF with a GF Score™ of 33/100 and a GF Value™ of $0.39 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,431 Biotechnology companies, Telescope Innovations ranks worse than 64.71% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Telescope Innovations's share price for the quarter that ended in May. 2026 was $0.45. Telescope Innovations's Shares Outstanding (EOP) for the quarter that ended in May. 2026 was 80.81 Mil. Therefore, Telescope Innovations's market cap for the quarter that ended in May. 2026 was $36.36 Mil.

Telescope Innovations's quarterly market cap declined from Nov. 2025 ($21.12 Mil) to Feb. 2026 ($21.01 Mil) but then increased from Feb. 2026 ($21.01 Mil) to May. 2026 ($36.36 Mil).

Telescope Innovations's annual market cap increased from Aug. 2023 ($9.12 Mil) to Aug. 2024 ($18.94 Mil) but then declined from Aug. 2024 ($18.94 Mil) to Aug. 2025 ($14.19 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Telescope Innovations's Enterprise Value for Today is $44.78 Mil.


Telescope Innovations  (OTCPK:TELIF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Telescope Innovations Market Cap Related Terms


Telescope Innovations Market Cap Historical Data

* Premium members only.

The historical data trend for Telescope Innovations's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations Market Cap Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24 Aug25
Market Cap
Get a 7-Day Free Trial 0.00 13.17 9.12 18.94 14.19

Telescope Innovations Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.48 14.19 21.12 21.01 36.36

TELIF vs VRTX, REGN, ALNY: Market Cap Comparison

For the Biotechnology subindustry, Telescope Innovations's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telescope Innovations Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Market Cap distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Market Cap falls into.


TELIF
33GF Score
Telescope Innovations Corp TELIF
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telescope Innovations Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Telescope Innovations's Market Cap for the fiscal year that ended in Aug. 2025 is calculated as

Market Cap (A: Aug. 2025 )=Share Price (A: Aug. 2025 )*Shares Outstanding (EOP) (A: Aug. 2025 )
=$0.2643*53.698
=$14.19

Telescope Innovations's Market Cap for the quarter that ended in May. 2026 is calculated as

Market Cap (Q: May. 2026 )=Share Price (Q: May. 2026 )*Shares Outstanding (EOP) (Q: May. 2026 )
=$0.45*80.805
=$36.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $43.81 Mil mean?
Telescope Innovations (TELIF) has a Market Cap of $43.81 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Telescope Innovations and its competitors. According to the industry distribution chart, Telescope Innovations ranks #926 out of 1431 companies in the Biotechnology industry, placing it in the top 64.7%.
Is Telescope Innovations' Market Cap too high?
Telescope Innovations' current Market Cap is $43.81 Mil. The Biotechnology industry median Market Cap is 113.83. Telescope Innovations' value of $43.81 Mil is 61.5% below this industry median. Based on the distribution chart, Telescope Innovations ranks #926 out of 1431 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Telescope Innovations has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #926 out of 1431 companies for Market Cap. This places Telescope Innovations in the lower half of its industry. The industry median Market Cap is 113.83. Telescope Innovations' value of $43.81 Mil is 61.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telescope Innovations's current Market Cap of $43.81 Mil is 61.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Telescope Innovations and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telescope Innovations's current Market Cap is $43.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.39, compared to a current price of $0.56 — trading 43.3% above its estimated fair value. The current Market Cap is $43.81 Mil and 61.5% below the Biotechnology industry median of 113.83. Telescope Innovations' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Market Cap is $43.81 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.56 is trading 43.3% above its estimated GF Value™ of $0.39. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Market Cap: $43.81 Mil
  • GF Value™: $0.39 vs. price of $0.56 (43.3% above fair value)
  • GF Score™: 33/100 with 1 warning sign
  • Industry Position: 61.5% below the Biotechnology median (#926 of 1431)

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
33GF Score

Get the complete analysis for TELIF

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.39
GF Value